21 Ensuring consistent access to GLP-1 RA therapy is crucial for minimizing GI AEs
While vital for glucose control, insulin is also a potent growth factor that can "fuel" the proliferation and survival of cancer cells
April 25, 2022
Nausea, vomiting, diarrhea, and constipation are frequently reported, especially during initial dose escalation phases
The progression of LN to ESKD is influenced by various factors, including the initial nephron number (determined at birth), episodes of nephron loss (during LN flare), and the rate of nephron loss beyond physiological aging (ongoing inflammation due to LN) or in some cases concomitant uncontrolled diabetes mellitus, and/or hypertension ( Effective management of LN during pregnancy is pivotal to minimizing maternal and fetal risks
Afkarian M, Sachs MC, Kestenbaum B, et al